While biotechnology has met with mixed public reactions, to date nanotechnology seems to invoke much less public concern.
Covering the life sciences inside and out
While biotechnology has met with mixed public reactions, to date nanotechnology seems to invoke much less public concern.
Celebrity spokespeople for pharma companies can manipulate the public’s understanding of disease.
Biomedical research can learn from citizen science, which is grounded in strong relationships with study participants.
The Scientist recounts the year’s top science prize winners and top-notch scientists that passed away.
Find the perfect present for the devoted life scientist in your life.
Prognostic signatures have become popular tools in cancer research, but it turns out signatures made of random genes are prognostic as well.
A snapshot of the most highly ranked articles in ecology, from Faculty of 1000
How next-generation sequencing technologies will drive a new era of research on non-model organisms.
Let us know what you like about The Scientist, and how we can improve our coverage of the life sciences.